Coma News and Research

RSS

Scientists create new models of tropical eye worm for development of anti-filarial drugs

Researchers at the LSTM's Centre for Drugs and Diagnostics, and University of Buea, Cameroon have developed new models of the tropical eye worm, Loa loa for the development of new drugs against filariasis.

30 Mar 2019

Simple urine test can rapidly detect preeclampsia

Researchers with The Ohio State University College of Medicine, The Ohio State University Wexner Medical Center and Nationwide Children's Hospital have found that a simple urine test can rapidly detect one of the world's deadliest pregnancy-related conditions, which could have a major impact on global health.

13 Mar 2019

Hidden FDA reports detail harm caused by scores of medical devices

Dr. Douglas Kwazneski was helping a Pittsburgh surgeon remove an appendix when something jarring happened. The surgical stapler meant to cut and seal the tissue around the appendix locked up.

7 Mar 2019

Diabetes' sworn enemy could also be a protective asset

Montreal research team unravels an adaptive mechanism involved in controlling insulin action, showing that glucagon plays a crucial part in it and can thus be a protective asset.

6 Mar 2019

Study: Number of calls to U.S. Poison Control regarding kratom exposure increased

In recent years, kratom has become popular as a treatment for chronic or acute pain as well as mood conditions such as depression and anxiety.

21 Feb 2019

OHSU paper recommends feeding tubes to be excluded from POLST

Following years of research that demonstrated feeding tubes can harm patients with dementia, the Journal of the American Geriatrics Society has published an OHSU opinion paper recommending patient preference for feeding tubes be excluded from Physician Order for Life-Sustaining Treatment, or POLST, forms.

1 Feb 2019

UC San Diego to conduct first U.S. clinical trial of intravenously administered bacteriophage therapy

The U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.

9 Jan 2019

Mass spectrometry throws light on old case of intentional heavy metal poisoning

In 1994, Chinese university student Zhu Ling began experiencing stomach pain, hair loss and partial paralysis.

14 Dec 2018

Study: Thalamus is not a critical part of the brain pathway involved in maintaining consciousness

With a finding that will "rewrite neuroanatomy textbooks," University of Iowa neurologist Aaron Boes, MD, PhD, and his colleagues show that the thalamus is not a critical part of the brain pathway involved in keeping humans awake and conscious.

29 Nov 2018

First probabilistic atlas of thalamus nuclei to better understand the brain

A multidisciplinary study led by BCBL, a Basque research center, opens the door to the investigation of the structure and functions of human thalamic nuclei and their involvement in Alzheimer's, dyslexia, epilepsy, Huntington's and schizophrenia.

20 Nov 2018

Regenerative medicine scientist receives $1.3 million to study stem cell therapy for liver failure

Currently, the only therapy for metabolic liver disease is an organ transplant. Tracy Grikscheit, MD, an attending physician and regenerative medicine scientist at Children's Hospital Los Angeles, hopes to change that reality.

7 Nov 2018

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma.

11 Oct 2018

Regular use of party drug GHB associated with brain changes

Scientists have discovered that regular use of the party drug GHB, and especially unconsciousness following GHB use, is associated with brain changes including negative effects on long-term memory, working memory, IQ, and higher levels of stress and anxiety.

8 Oct 2018

Measures to predict and prevent carbon monoxide poisoning after storm

Severe weather events, such as summer hurricanes, tornadoes, and winter snow storms often result in widespread and prolonged power outages, interrupting essential household functions, including home heating.

27 Sep 2018

One in five diabetes inpatients experienced hypoglycemia during hospital stay

Diabetes UK is urging healthcare professionals to be hypo-aware for Hypo-awareness Week (24th- 30th September). The charity wants to raise awareness about hypoglycemia and is encouraging healthcare professionals working in hospitals to look out for the signs of hypoglycemia and ensure those at high risk are given the necessary support.

25 Sep 2018

Eagle Pharmaceuticals completes enrollment of second clinical study to evaluate safety, efficacy of RYANODEX

Eagle Pharmaceuticals, Inc. today announced completion of enrollment of the Company's second clinical study to further evaluate the safety and efficacy of RYANODEX® (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke, an investigational new indication for the product.

30 Aug 2018

Scientists demonstrate how medical test results can be remotely modified

A team of physicians and computer scientists at the University of California has shown that it is easy to modify medical test results remotely by attacking the connection between hospital laboratory devices and medical record systems.

29 Aug 2018

World not ready to deal with a viral pandemic

A team of researchers from the John Hopkins Center for Health Security conducted a simulation with real life implications.

31 Jul 2018

Study supports clinical role of biomarker test to rule out the need for CT scan in TBI patients

Banyan Biomarkers, Inc., a pioneer in developing biomarkers for traumatic brain injury (TBI), today announced the publication of the results for the ALERT-TBI study, an international, multicenter clinical trial utilizing the Banyan Brain Trauma Indicator.

26 Jul 2018

FDA requires safety labeling changes for fluoroquinolones to strengthen warnings on adverse reactions

The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.

11 Jul 2018